COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)			3 Months Ended		9 Months Ended		12 Months Ended
	May 08, 2023	Nov. 09, 2021	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]
Net Loss			$ 3,390,376	$ 981,288	$ 5,177,713	$ 1,035,001
Accrued offering costs			378,300		378,300
Accounts payable and accrued expenses			429,100		429,100
Forward Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Derivative liability issued					453,701
Derivative liability issued					$ 5,338,558		$ 2,045,845
Sponsor [Member]
Subsidiary, Sale of Stock [Line Items]
Shares subject to forfeiture		406,250
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued during period shares issued in initial public offering		2,500,000
Share price		$ 10.00
Proceeds from issuance of common stock		$ 25,000,000
Over-Allotment Option [Member] | Underwriting Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Additional units purchased					4,125,000
Cash underwriting discount price					$ 0.20
Payment of underwriting discount					$ 6,000,000
Deferred underwriting fee price					$ 0.35
Deferred underwriting fee			$ 10,500,000		$ 10,500,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued during period shares issued in initial public offering	3,000,000	30,000,000
Legal fees					$ 807,470		$ 584,300